新型冠状病毒肺炎辨证论治的临床体会

Abstract
Figure/Table
References (20)
Related Citation (15)

Download: PDF (688 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract The coronavirus disease 2019 coronavirus disease 2019 epidemic is spreading all over the world with strong infectivity and epidemic. It belongs to the category of “pestilence” disease of TCM. According to the pathogenesis and clinical features of coronavirus disease 2019, with “dampness-toxicity and pestilence” as the pathogenesis, “lunge” and “spleen” as the cores of the disease, and dampness, heat, toxicity, blood stasis and qi deficiency as the main syndrome points, through three cases of “diarrhea”, “cough” and “short breath and chest distress”, this paper expounds that coronavirus disease 2019 patients without fever should be treated according to the traditional Chinese medicine thinking of one-person-one-prescription and treatment based on syndrome differentiation. Huoxiang Zhengqi Powder, Sangbei Zhisou Powder, Xiaoxian Xiong Decoction, Tingli Dazao Xiefei Decoction and Qianjin Weijing Decoction are used to improve the symptoms of patients, reduce the toxin, cut off and reverse the course of disease, and mobilize the body’s own resistance to disease. Traditional Chinese medicine treatment based on syndrome differentiation of coronavirus disease 2019has unique advantages in improving clinical symptoms, reducing complications and improving quality of life.

Key words： Coronavirus disease 2019 Dampness-toxicity and pestilence Treatment based on syndrome differentiation Clinical experience

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	JIANG Lei WANG Fei YANG Jing LI Meifang WANG Cui JIN Yu

Cite this article:

JIANG Lei WANG Fei YANG Jing LI Meifang WANG Cui JIN Yu. Clinical experience of the treatment of coronavirus disease 2019 based on syndrome differentiation[J]. 中国医药导报, 2021, 18(5): 139-142.

URL:

http://www.yiyaodaobao.com.cn/EN/ OR http://www.yiyaodaobao.com.cn/EN/Y2021/V18/I5/139

[1] Huang C，Wang Y，Li X，et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan，China [J]. Lancet（London，England），2020，395（10223）：497-506.
[2] Tian S，Hu N，Lou J，et al. Characteristics of COVID-19 infection in Beijing [J]. J Infect，2020，80（4）：401-406.
[3] Chen N，Zhou M，Dong X，et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan，China：a descriptive study [J]. Lancet（London，England），2020，395（10223）：507-513.
[4] Sun P，Qie S，Liu Z，et al. Clinical characteristics of hospitalized patients with SARS-CoV-2 infection：a single arm meta-analysis [J]. J Med Virol，2020，92（6）：612-617.
[5] 李爱新，梁连春，李侗曾，等.新型冠状病毒肺炎合并心血管疾病患者临床特征与预后影响因素分析[J].河北医学，2020，26（6）：897-904.
[6] 伍伟，黄河颂，俞桥，等.新型冠状病毒肺炎T淋巴细胞亚群变化的临床分析[J].河北医学，2020，26（6）：905-908.
[7] 韩宁，杜凌遥，严丽波，等.新型冠状病毒介导炎症反应的机制及治疗策[J].生物医学工程学杂志，2020，37（4）：1-2.
[8] 王玉光，齐文升，马家驹，等.新型冠状病毒肺炎中医临床特征与辨证治疗初探[J].中医杂志，2020，61（4）：281-285.
[9] 董国菊.新型冠状病毒肺炎中医诊治思路之我见[J].中国中医基础医学杂志，2020，26（2）：269-271.
[10] 王靖云.藿香正气散加减治疗胃肠功能紊乱的临床效果分析[J].中国实用医药，2020，15（9）：154-156.
[11] 霍志鹏，刘元雪，郝磊，等.藿香正气防治新型冠状病毒肺炎潜在应用的研究进展[J].现代药物与临床，2020， 35（3）：405-410.
[12] 李庆洁.藿香正气散联合西药治疗轮状病毒肠炎206例[J].现代中医药，2010，30（2）：42-43.
[13] 汪曼云.藿香正气散治疗诺如病毒感染性腹泻22例[J].内蒙古中医药，2010，29（6）：8.
[14] 刘忠华，张薇，林培政，等.不同中药复方对禽流感病毒感染模型小鼠的影响[J].广州中医药大学学报，2010， 27（3）：208-213.
[15] 熊继柏.国医大师熊继柏谈《湖南省新型冠状病毒肺炎中医药诊疗方案》[J].湖南中医药大学学报，2020，40（2）：123-128.
[16] 陈青扬，刘佑辉，王伟，等.国医大师熊继柏对新型冠状病毒肺炎的辨治方略[J].湖南中医药大学学报，2020， 40（3）：267-270.
[17] 朱成功，赵亭亭，谢雪姣，等.从新型冠状病毒肺炎防治策略探讨国医大师熊继柏用药特点[J/OL].中国中医药信息杂志.[2020-07-30].http：//kns.cnki.net/kcms/detail/11.3519.R.20200526.0834.004.html.
[18] 新型冠状病毒肺炎诊疗方案（试行第七版）[J].传染病信息，2020，33（1）：1-6，26.
[19] 刘茜，王荣帅，屈国强，等.新型冠状病毒肺炎死亡尸体系统解剖大体观察报告[J].法医学杂志，2020，36（1）：21-23.
[20] 新型冠状病毒肺炎诊疗方案（试行第七版）中医方案部分（第二部分）国家中医药管理局[J].实用中医内科杂志，2020，34（4）：35.